SCHEMBL4235368

SCHEMBL4235368

CCN(CCCN1CCCCC1)c1ccc(C(=O)O)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.47
KDM4E B2RXH2 4/20 0.47
KMT2A Q03164 2/20 0.47
MEN1 O00255 1/20 0.47
GFER P55789 1/20 0.47
HRH3 Q9Y5N1 4/20 0.46
LMNA P02545 3/20 0.41
CYP2D6 P10635 2/20 0.41
KCNH2 Q12809 2/20 0.41
ADRA2C P18825 2/20 0.41
THRB P10828 2/20 0.41
ACHE P22303 2/20 0.41
CYP1A2 P05177 1/20 0.41
CHRM2 P08172 1/20 0.41
CHRM4 P08173 1/20 0.41
CHRM5 P08912 1/20 0.41
CYP2C9 P11712 1/20 0.41
DRD4 P21917 1/20 0.41
SLC6A2 P23975 1/20 0.41
HRH2 P25021 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4229105 0.82 ADRA2A (0.48) ALDH1A1KDM4EKMT2AHRH3CYP2D6
SCHEMBL4239226 0.77 HRH3 (0.55) ALDH1A1KDM4EKMT2AMEN1GFER
SCHEMBL14430710 0.77 MAPT (0.58) ALDH1A1KMT2AMEN1LMNACYP2D6
SCHEMBL4240951 0.76 ALDH1A1 (0.49) ALDH1A1KMT2AMEN1GFERHRH3
SCHEMBL4233535 0.76 PDK1 (0.49) ALDH1A1KDM4EKMT2AGFERHRH3
SCHEMBL7471413 0.75 EGFR (0.58) ALDH1A1KDM4EKMT2AMEN1LMNA
SCHEMBL64440 0.74 MEN1 (0.56) ALDH1A1KDM4EKMT2AMEN1GFER
SCHEMBL6209135 0.74 PDK1 (0.47) ALDH1A1KDM4EKMT2AGFERHRH3
SCHEMBL4235478 0.73 HRH1 (0.47) KDM4EHRH3KCNH2ACHEHRH1
Hydrochloric Acid SCHEMBL5071191 0.73 PDK1 (0.47) ALDH1A1KDM4EKMT2AMEN1GFER

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090233910-A1 Npy antagonists, preparation and uses CEREP (FR) 2009-09-17 US disclosed
US-20090233910-A1 Npy antagonists, preparation and uses CEREP (FR) 2009-09-17 US disclosed
US-20090233910-A1 Npy antagonists, preparation and uses CEREP (FR) 2009-09-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090233910-A1 Npy antagonists, preparation and uses NPY1R, NPY5R, NPY2R ALDH1A1 4542/4885KDM4E 1604/4885KMT2A 3436/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.